Disclaimer: All products are for laboratory research only and not for human or animal use or consumption. For in-vitro research by qualified professionals only
$220.00
373 in stock (can be backordered)
Ships today if ordered and paid by 12 PM EST. (Except Saturdays & Sundays)
Due to our rigorous quality control standards and the fragile nature of our products, we cannot accept returns. In the rare occasion that your order arrives with missing, incorrect or damaged items, please email info@peptidessource.is for assistance. Our customer support representatives are standing by to ensure that our customers are 100% satisfied with our product quality, customer support and delivery. Cancellations must be requested by email before the order shipment has shipped. Once the order has shipped you may not cancel your order. Please contact us at info@peptidessource.is with any questions or concerns that you may have regarding your order. We will do our absolute best to assist you as quickly and satisfactorily as possible.Thank you.
GLP-3 (RTA) is a multi-receptor incretin research peptide active at the GLP-1, GIP and glucagon receptors, and one of the most sought-after compounds in metabolic and incretin-pathway research. This listing supplies the 20mg lyophilized vial for laboratory research use. Every batch is tested to at least 98% purity by HPLC with a certificate of analysis (COA), is USA-made and third-party verified. For research use only; not for human or veterinary use or consumption.
GLP-3 (RTA) is a single-molecule agonist active at three incretin-related receptors: the GLP-1, GIP and glucagon receptors. In preclinical systems researchers use it as a tool compound to study simultaneous multi-receptor incretin signalling and how combined receptor activity compares with single- and dual-agonist compounds. This describes a research mechanism only.
Multi-receptor incretin agonism has been examined in in-vitro receptor assays and animal metabolic-model research. GLP-3 (RTA) is used to probe how combined GLP-1, GIP and glucagon receptor activity behaves relative to single- and dual-agonist research peptides. All referenced work is preclinical and mechanistic; no human data or outcomes are implied.
Typical applications include comparative receptor-signalling studies alongside single-agonist (GLP-1 (SMA)) and dual-agonist (GLP-2 (TRZ)) research peptides and amylin analogs such as Cagrilintide, plus metabolic-pathway model work. Browse the full metabolic & incretin research range for related material.
This is a lyophilized (freeze-dried) vial. Reconstitute in the laboratory before study using a suitable diluent such as bacteriostatic water. Store the sealed vial frozen; keep reconstituted material refrigerated and protected from light. Handle only in a controlled laboratory setting. For research use only, not for human or veterinary use or consumption.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, consumption, diagnosis or treatment. Statements describe a preclinical research context only and are not medical claims.